TAMPA, FL / ACCESS Newswire / November 20, 2025 / (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

A growing number of people are searching for weight loss options that feel manageable in daily life. Many of the current ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

Eli Lilly, the drugmaker company’s valuation has soared to $1 trillion as the demand grows due to the weight-loss boom. This ...

As the market for weight management and anti-obesity grows rapidly in India, diagnostic players are hoping to cash in on the ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...